Displaying 501 - 520 of 1505
CentraCare Health System, In the Matter of
The FTC's order requires CentraCare Health, a healthcare provider in St. Cloud, Minnesota, to release some physicians from “non-compete” contract clauses, allowing them to join competing practices, under a settlement mitigating likely anticompetitive effects from CentraCare’s proposed merger with St. Cloud Medical Group (“SCMG”). CentraCare Health, a non-profit health system in central Minnesota, also includes a multi-specialty physician practice group. SCMG is a physician-owned, multi-specialty practice group that operates four clinics in and around St. Cloud. According to the FTC, CentraCare’s planned acquisition of SCMG would combine the two largest providers of adult primary care, pediatric, and OB/GYN services in the St. Cloud area. By eliminating SCMG as a potential alternative in the St. Cloud area, the acquisition would likely increase CentraCare’s bargaining power vis-à-vis commercial health plans, allowing it to raise reimbursement rates and secure more favorable terms, the complaint states. However, SCMG was failing financially, and a number of physicians had already left the practice. SCMG’s multi-year search did not identify an alternative purchaser to CentraCare for the entire group, but at least one local provider has expressed interest in expanding its practice by hiring some of SCMG’s physicians. The consent order permitted the acquisition to proceed, but lessened its potential anticompetitive effects by requiring CentraCare to allow a number of adult primary care, pediatric, and OB/GYN physicians to leave the health system and work for other local providers or establish a new practice in the area and to provide certain financial incentives to a number of departing physicians.
FTC Staff Provides Supplemental Public Comment in Tennessee Opposing Health Systems’ Certificate of Public Advantage Application
FTC Announces Workshop on Hearing Health and Technology
Abbott Laboratories and St. Jude Medical, In the Matter of
Abbott Laboratories agreed to divest two medical device businesses to settle FTC charges that its proposed $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive. The FTC’s complaint alleges that without a remedy, the proposed acquisition would harm competition in the U.S. markets for vascular closure devices, which are used to close holes in arteries from the insertion of catheters, and for “steerable” sheaths, which are used to guide catheters for treating heart arrhythmias. Without a remedy, the merger will cause significant harm to competition in these two markets. The consent order requires the parties to divest to Tokyo-based medical device maker Terumo Corporation all rights and assets related to St. Jude’s vascular closure device business and Abbott’s steerable sheath business. The order requires both companies to assist Terumo with establishing its manufacturing capabilities. Under the order, Abbott is also required to notify the FTC if it intends to acquire lesion-assessing ablation catheter assets from Advanced Cardiac Therapeutics, known as ACT. Lesion-assessing ablation catheters provide feedback to physicians regarding the force being applied by the catheter or the temperature of the ablation target. Currently, only St. Jude and one other company provide lesion assessing ablation catheters in the United States. Abbott and ACT have formed a partnership to develop these catheters. After the acquisition of St. Jude, if Abbott acquired lesion-assessing ablation catheter assets from ACT, it could eliminate additional competition that would result from an independent ACT.
FTC Staff Supports Proposal for Flexible Physician Supervision of Physician Assistants in Iowa
16 CFR Part 315: Contact Lens Rule; Notice of Proposed Rulemaking; Request for Public Comment
FTC Staff Comment To the Delaware Board of Speech/Language Pathologists, Audiologists and Hearing Aid Dispensers Regarding Its Proposed Revisions To Its Telecommunication and Telehealth Regulations
FTC Staff Comment: Proposal to Expand Access to Telehealth Services Could Benefit Delaware Speech and Hearing Patients
FTC Staff Provides Public Comment and Testimony in Tennessee Opposing Certificate of Public Advantage Application
Tennessee Department of Health Public Hearing Testimony
FTC Staff Submission to the Tennessee Department of Health Regarding the Certificate of Public Advantage Application of Mountain States Health Alliance and Wellmont Health System
FTC Seeks Comment on Proposed Changes to Contact Lens Rule
FTC Amicus Brief Urges Appeals Court to Reverse District Court’s Dismissal of Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc., et al. v. Momenta Pharmaceuticals, Inc., et al.
Statement from Federal Trade Commission’s Bureau of Competition Director on Appeals Court Decision to Remand Advocate/North Shore Hospital Merger Case to District Court for Further Action
The Penn State Hershey Medical Center/PinnacleHealth System, In the Matter of
The Commission issued an administrative complaint alleging that the combination of Penn State Hershey Medical Center and PinnacleHealth System would substantially reduce competition for general acute care inpatient hospital services in the area surrounding Harrisburg, Pennsylvania, and lead to reduced quality and higher health care costs for the area’s employers and residents. The Commission also authorized staff to file a preliminary injunction to maintain the status quo pending the outcome of its administrative proceeding.
Mylan Pharmaceuticals Inc. v. Warner Chilcott PLC
Penn State Hershey Medical Center, FTC and Commonwealth of Pennsylvania v.
The FTC issued an administrative complaint and authorized staff to file a preliminary injunction to block Penn State Hershey Medical Center's proposed merger with PinnacleHealth System. The complaint alleged that combining the two health care providers would substantially reduce competition for general acute care inpatient hospital services sold to commercial health plans iin four south-central Pennsylvania counties, leading to reduced quality and higher prices for employers and residents.
Displaying 501 - 520 of 1505